Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Pathophysiology, Mechanism, Diagnosis and Management of PAH

Published:

28 January 2026

Citation:

US Cardiology Review 2026;20:e01.

MicroRNAs for Cardiac Regeneration

Published:

22 September 2025

Citation:

European Cardiology Review 2025;20:e26.

EPCs and Innovative Strategies for Endothelial Dysfunction in Heart Failure

Published:

18 August 2025

Citation:

Cardiac Failure Review 2025;11:e21.

Uric Acid Metabolism in the Pathophysiology of Ischaemic Heart Disease

Published:

12 June 2025

Citation:

European Cardiology Review 2025;20:e18.